Introduction
The use of conformationally restricted nucleotide monomers in antisense oligonucleotides is of significant interest due to their constrained sugar puckering, which can mimic a DNA-or RNAtype furanose ring conformation. This may promote several advantages with respect to antisense capability such as increasing thermal stability towards targeted mRNA, efficient cleavage of targeted mRNA by activation of RNase H, and stability against nucleolytic degradation. 1, 2 Prominent examples of conformationally restricted oligonucleotides are locked nucleic acid (LNA) 3 and its stereoisomer α-L-LNA, 4 both having a C2'-O4' methylene bridge ( Fig. 1) , which efficiently locks the furanose rings in a 3'-endo (North-type) pseudorotational conformation.
When singly incorporated into oligonucleotides, these two monomers increase the thermal stability of duplexes with complementary DNA or RNA very significantly when compared to the thermal stability of the corresponding unmodified oligonucleotides. 5 Oligonucleotides containing LNA in the wings of so-called gapmers have been shown to successfully activate RNase H and thus to mediate cleavage of targeted RNA. In addition, incorporation of several LNA nucleotides lead to a substantial increase in the stability in human serum compared to an unmodified oligonucleotide. 6 Another group of conformationally restricted nucleotides contains an oxetane ring system where the methylene bridging is linking either C1'-O2', 1,7-10 O2'-C3' 11, 12 or O3'-C4'. 5, [13] [14] [15] . The C1'-O2' oxetane derivatives ( Fig. 1 ) adopt a North-East pseudorotational conformation when incorporated into oligonucleotides (phosphodiester 3'-5'-linkage) and affects the thermodynamic stability of duplexes formed with complementary RNA by a decrease of approximately 6 °C per incorporated pyrimidine monomer while incorporation of purine monomers has no effect. 9 In certain configurations this oxetane nucleotide monomer has been shown to be compatible with RNase H activity when hybridized to RNA, 2 to give protection against endonucleases, 7 and to be useful as modification in siRNA constructs. 16 Other members of the oxetane nucleotide family include oxetane nucleic acid (ONA) 13 and α-L-ONA 5 with a O3'-C4' methylene bridge (Fig. 1 ).
These adopt a 2'-endo (South-type) pseudorotational conformation, and when incorporated into oligonucleotides (phosphodiester 2'-5'-linkage) they show a selectivity for RNA over DNA and a significant decrease in thermal stability against complementary DNA and RNA. 17 It is also 3 relevant to mention that several 2'-C-methylribonucleosides are selective inhibitors of HCV replication including the FDA approved drug Sofosbuvir as the most prominent compound. 18 Herein we describe the synthesis of two novel constrained ribonucleotide phosphoramidites bearing a 2'-C-methyl substituent and either a O2'-C4' (LNA-analogue) or a O3'-C4' (ONAanalogue) methylene bridge. Furthermore, their incorporation into oligonucleotides as monomers X and Y (Fig. 1) and their effects on duplex stability were studied.
Fig. 1
Chemical structures of conformational restricted nucleic acid analogues incorporated as phosphodiesters into oligonucleotides. B = nucleobases, U = uracil-1-yl and T = thymin-1-yl. LNA, 3 α-L-LNA, 4 C1'-O2'-ONA, 1,7-10 O2'-C3'-oxetane-ANA, 11, 12 ONA 5, [13] [14] [15] and α-L-ONA. 5 4 the first step the 2'-and 3'-hydroxy groups were protected using a cyclohexane ketal protecting group affording intermediate 2 in 90% yield. A Swern-oxidation followed by an Aldol-Cannizarro reaction gave the 4'-hydroxymethyl derivative 3 in 40% yield over three steps from 2. The two primary hydroxy groups were mesylated giving nucleoside 4 as an intermediate and the cyclohexane ketal protecting group was subsequently removed using 80% aqueous TFA giving the key intermediate 5 suitable for the subsequent ring closure reaction (76% yield over two steps). Scheme 1 Synthesis of the bicyclic precursors 6a and 6b. U = uracil-1-yl.
The ring closure of the bis-mesylate 5 into a mixture of the corresponding bicyclic nucleosides 6a or 6b was optimized. Our expectation was that the presence of the 2'-C-methyl substituent would exert a conformational effect due to its preference for an axial orientation enabling a higher yield of the LNA-type derivative 6a than observed for the corresponding reaction with a similar precursor having a H-atom in the 2'-beta position. [13] [14] [15] 19 Using NaH and performing the reaction at room temperature ( Table 1 , entry 1) resulted in isolation of 6a and 6b in yields of 22% and 12%, respectively. Performing the cyclization reaction at a temperature of 120 °C (Table 1 , entry 2) reversed the selectivity giving 6a and 6b in yields of 15% and 25%, respectively. Substantial amounts of material from side reactions were, however, isolated under both conditions. Following these observations, attempts to improve the reaction were made. In one setting, the solution containing 5 was cooled to 0 °C followed by addition of NaH in two 5 equal portions and then allowing the mixture to react at room temperature overnight (Table 1, entry 3), which afforded 6a and 6b in approximately 34% yield of each. A subsequent attempt splitting the amount of NaH into three portions and allowing the reaction mixture to react for one day at 0 °C followed by another one day at room temperature ( Table 1 , entry 4) did not improve the outcome of the reaction. The structure assigned to the LNA-and ONA-type derivatives 6a and 6b were confirmed by comparison of data reported earlier for similar LNA 3,5 and ONA nucleosides. 14 Table 1 Ring closure of compound 5 into the LNA-analogue 6a and ONA-analogue 6b a Yields of isolated products. b NaH was added in 2 portions. c NaH was added in 3 portions. d Yields are only estimated due to the presence of minor impurities as evidenced by NMR analysis.
Next the LNA-type and ONA-type derivatives 6a and 6b were converted into the corresponding O3' and O2' phosphoramidites, respectively in four synthetic steps (Scheme 2). Converting the 5'-C-mesyloxy groups into the corresponding 5'-hydroxy groups was performed through formation of 5'-O-benzoyl intermediates followed by alkaline ester hydrolysis as reported earlier for an analogous substrate 20 giving derivatives 7a and 7b, respectively. Compounds 7a and 7b were 5'-O-DMTr-protected giving 8a and 8b, respectively. Eventually, phosphitylation was carried out giving the phosphoramidite derivatives 9a and 9b by using 2-cyanoethyl-N,N,N',N'tetraisopropylphosphordiamidite as the phosphitylating reagent and N,N-diisopropylamine tetrazolide (DIPAT) as activator. All conversions described above proceeded in satisfactory yields (all estimated to be above 70%), but relative yields were not calculated due to the presence of minor impurities as evidenced by NMR analyses (see ESI). Scheme 2 Synthesis of the phosphoramidite derivatives 9a and 9b. U = uracil-1-yl, DMTr = 4,4'dimethoxytrityl, PN2-reagent = 2-cyanoethyl-N,N,N',N'-tetraisopropylphosphordiamidite, DIPAT = N,N-diisopropylamine tetrazolide.
Oligonucleotide synthesis
The 2'-C-Me-LNA and 2'-C-Me-ONA phosphoramidites 9a and 9b, respectively, were successfully used in automated ON synthesis on a commercial nucleic acid synthesizer. The stepwise coupling yields were ∼80% for the 2'-C-Me-LNA phosphoramidite 9a employing "hand coupling conditions" 17 and ∼99% for standard DNA and LNA phosphoramidites.
Following the coupling of the 2'-C-Me-ONA phosphoramidite 9b, an oxidation step using a 0.5 M solution of (1S)-(+)-(10-camphorsulfonyl)oxaziridine (CSO) 22 in anhydrous MeCN was applied followed by capping. The non-aqueous oxidizer CSO was used as we expected that the phosphotriester, formed from coupling using the tertiary phosphoramite 9b, would be liable to an elimination reaction if the standard aqueous iodine oxidation was used. 21 Thermal denaturation experiments 9-Mer DNA-based sequences were synthesized with incorporations of either the 2'-C-Me-LNA monomer X (ON2 and ON5) or the 2'-C-Me-ONA monomer Y (ON7-ON9). In order to evaluate the effect of the monomers X and Y on duplex stability, ON1-ON9 were hybridized to complementary DNA or RNA and thermal denaturation experiments were conducted in a medium salt buffer ( Table 2) .
When ON2 with one incorporation of monomer X was hybridized to DNA or RNA a The experiment was carried out in medium salt buffer (6.1 mM sodium phosphate, 100 mM sodium chloride, 0.1 mM EDTA, pH 7.0) using 1.5 µM concentrations of the two complementary strands (assuming identical extinction coefficients for all modified and unmodified oligonucleotides); X = 2'-C-Me-LNA-monomer, T L = LNA-T monomer, Y = 2'-C-Me-ONA uridine phosphodiester monomer, A = adenin-9-yl monomer, C = cytosin-1-yl monomer, G = guanin-9-yl monomer and T = thymin-1-yl monomer.
Crystal structure of LNA intermediates
To gain insight into why the 2'-C-Me-LNA monomer X has such a pronounced duplex destabilizing effect, the possibility of obtaining a crystal structure of a relevant nucleoside intermediate was investigated. It was possible to crystalize 6a as well as to synthesize and crystalize 5'-OMs-LNA-T 11 23 (Scheme 3), and the crystals of these two structures were analyzed and compared to study the steric effects of the 2'-Me substituent present in 6a.
Scheme 3 Synthesis of 5'-OMs
The molecular structures of 6a and 11 are shown in Fig 
Experimental section
NMR spectra were recorded on a Bruker AVANCE III 400 ( 1 H at 400 MHz, 13 C at 101 MHz and 31 P at 162 MHz). All samples were dissolved in DMSO-d 6 . Chemical shifts are reported in ppm relative to solvent peak ( 1 H, internal standard, δ H 2.500 ppm; 13 C, internal standard, δ C 39.520 ppm) or 85% H 3 PO 4 ( 31 P, external standard, δ P 0.000 ppm). Assignments of the NMR signals are based on 2D correlation spectroscopy. Standard nucleoside atom-numbering is used for assignment of NMR signals. High-resolution MS spectra were recorded by electrospray ionization in positive mode on a Bruker MicrOTOF-Q II. ONs were synthesized on an Expedite™ nucleic acid synthesis system (PerSeptive Biosystems). The compositions of ONs were confirmed by MALDI-MS on a Microflex MALDI-TOF MS (Bruker Daltronics), purifications were performed by reversed-phase HPLC on a Waters 600 system, and purities were determined by ion-exchange HPLC on a LaChrom L-7000 system (Merck Hitachi).
2',3'-O-Cyclohexylidene-2'-C-methyluridine (2)
To a flame-dried 250 mL RB was added 2'-C-methyluridine (10.0 g, 38.73 mmol), ptoluenesulfonic acid monohydrate (744 mg, 3.873 mmol), anhydrous THF (65 mL) and 1,1- 
2',3'-O-Cyclohexylidene-4'-C-hydroxymethyl-2'-C-methyluridine (3)
A flame-dried 3-necked 500 mL RB was evacuated and filled with argon gas several times whereupon anhydrous DCM (200 mL) was added and cooled to -78 °C under an atmosphere of argon. Oxalyl chloride (5.46 mL, 63.4 mmol) was added, and the resulting mixture was stirred for 30 min. Anhydrous DMSO (9.1 mL, 126.7 mmol) was slowly added dropwise to ensure that the temperature did not rise above -70 °C, and afterwards was stirring continued for 20 min at - Na + ], C 19 H 28 N 2 O 11 S 2 ·Na + calc. 547.1020).
5'-O-Mesyl-4'-C-mesyloxymethyl-2'-C-methyluridine (5)
Compound 4 (3.23 g) was suspended in cold 80% aqueous TFA (25 mL) resulting in a red/orange solution. After stirring for 4 days at r.t. TLC showed full consumption of starting material, and the mixture was evaporated to dryness under reduced pressure to give an orangebrownish oil. Upon addition of DCM, a precipitate was formed, filtered and collected. The filtrate was evaporated to dryness under reduced pressure and another precipitation was performed. The combined product 5 (2.19 g, 76% yield calculated for two steps from compound 
5'-O-Mesyl-2'-O,4'-C-methylene-2'-C-methyluridine (6a) and 5'-O-mesyl-3'-O,4'-Cmethylene-2'-C-methyluridine (6b)

5'-O-(4,4'-Dimethoxytrityl)-2'-C-methyl-3'-O,4'-C-methyleneuridine (8b)
UV duplex melting studies
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To determine duplex melting temperatures (T m ), UV melting studies were carried out on a Perkin Elmer Lambda 35 UV/Vis Spectrometer using Hellma SUPRASIL synthetic quartz 10 mm path length cuvettes, monitoring at 260 nm with a complementary DNA/RNA strand concentration of each strand of 1.5 µM and a volume of 1.0 mL. Samples were prepared as follows: All oligonucleotide sequences were dissolved in medium salt buffer (100 mM sodium chloride, 6.1 mM sodium phosphates, 0.1 mM EDTA and at pH 7.0); the modified sequences and complementary strands were mixed in a 1:1 ratio and medium salt buffer was added to give a total volume of 1.0 mL. The samples were transferred to cuvettes, denatured by heating to 80 °C and cooling to 5 °C followed by recording UV absorbance as a function of increasing temperature from 5 °C at a rate of 1.0 °C pr. minute programmed by a Peltier temperature controller. Two separate melting curves were measured and T m -values were calculated using UV-WinLab Software, taking an average of the two melting curves with a deviation no more than 0.5 °C.
Crystallisation procedure for single crystal diffraction study
Crystals were grown in the following manner; 10 mg of product was placed in a glass vial and dissolved in acetone (3 mL). This vial was placed in beaker containing 20 mL petroleum ether. A lid was added to the beaker which was placed in a 5 °C refrigerator for slow diffusion of solvents and consequent crystallization. The crystals obtained had a white flaky appearance.
Crystal data on (6a) and (11)
Data for both crystals were collected at 100(1)K on a Synergy, Dualflex, AtlasS2 diffractometer using CuKα radiation (λ = 1.54184 Å) and the CrysAlis PRO 1.171.39.12b suite. 24 Using SHELXLE 25 the structure was solved by dual space methods (SHELXT 26 ) and refined on F 2 using all the reflections (SHELXL-2016 27 ). All the non-hydrogen atoms were refined using anisotropic atomic displacement parameters. Hydrogen atoms bonded to carbon were inserted at calculated positions using a riding model; those bonded to oxygen or nitrogen were located from difference maps and their coordinates refined. For compound 11, the methylsulfonate group of one molecule (C) was disordered, this was modelled as 56:44% occupancy of two conformations related by rotation about the C6C -S1C bond. Part of the pyrimidine group of molecule B was 23 also disordered; since this section is close to the disordered methylsulfonate it was modelled with the same 56:44% occupancy of two sites. In both cases, the absolute configuration was unambiguously established from the crystallographic data. Parameters for data collection and refinement are summarised in Table 4 . 
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